Literature DB >> 30248169

Complications of Androgen Deprivation Therapy in Men With Prostate Cancer.

Tejas Patil, Brandon Bernard.   

Abstract

The standard treatment for men with metastatic prostate cancer is androgen deprivation therapy (ADT). This therapy is associated with a multitude of side effects that can impact quality of life. These include vasomotor complications (in particular, hot flushes), sexual dysfunction and gynecomastia, osteoporosis, metabolic syndrome, and depression. Additionally, ADT has been associated with neurocognitive deficits, thromboembolic disease, and cardiovascular disease, although the data regarding the latter associations are mixed. This article summarizes the key side effects associated with ADT and discusses strategies to optimize management.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30248169

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  5 in total

1.  Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics.

Authors:  Shiv Verma; Eswar Shankar; F Naz Cemre Kalayci; Amrita Mukunda; Malek Alassfar; Vaibhav Singh; E Ricky Chan; Gregory T MacLennan; Sanjay Gupta
Journal:  Int J Mol Sci       Date:  2020-12-16       Impact factor: 5.923

Review 2.  A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer.

Authors:  Christopher C Khoo; Saiful Miah; Martin J Connor; Joseph Tam; Mathias Winkler; Hashim U Ahmed; Taimur T Shah
Journal:  Transl Androl Urol       Date:  2020-06

Review 3.  Percutaneous MR-guided prostate cancer cryoablation technical updates and literature review.

Authors:  Pierre de Marini; Roberto Luigi Cazzato; Julien Garnon; Behnam Shaygi; Guillaume Koch; Pierre Auloge; Thibault Tricard; Hervé Lang; Afshin Gangi
Journal:  BJR Open       Date:  2019-06-03

4.  Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer.

Authors:  Malgorzata K Nowakowska; Xiudong Lei; Mackenzie R Wehner; Paul G Corn; Sharon H Giordano; Kevin T Nead
Journal:  JAMA Netw Open       Date:  2021-12-01

5.  Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?

Authors:  Arnas Rakauskas; Taimur T Shah; Max Peters; Jagpal S Randeva; Feargus Hosking-Jervis; Michael J Schmainda; Clement Orczyck; Mark Emberton; Manit Arya; Caroline Moore; Hashim U Ahmed
Journal:  Urol Oncol       Date:  2021-05-26       Impact factor: 3.498

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.